Puration Announces First EVERx CBD Infused Bottled Water Order

DALLAS, Texas, December 13, 2016 /PRNewswire/ --

Puration Inc, (PURA ) today announced it had received a first order for its EVERx CBD Infused Bottled Water.  The first order is for 300 cases.  The Company just last week announced finalizing the EVERx brand logo and label design with plans to begin its first U.S. production run for delivery in the first quarter of 2017. Puration anticipates $1 million in EVERx CBD Infused Bottled Water sales in 2017. Management also plans to launch online Pre-Sales of EVERx CBD Infused Bottled Water before the end of this year.  

Cannabinoil (CBD) for Fitness and Wellness 

CBD is an ideal component of a pre and post workout regime.  CBD works as an anti-inflammatory and relieves muscle spasms.  CBD also works to relieve pain.  CBD protects the heart, lungs and brain. Often essential when it comes to high intensity and competitive training, CBD reduces nausea, increases appetite and aides sleep. Ongoing research continues in regard to CBD as a treatment for sports related head trauma. CBD is not just a good addition to an athletes training regime; It can be the foundation of a healthy wellness routine for everyone (CBD Athletic Recovery).

To learn more about North American Cannabis Holdings: growusmj.com. 
Follow the Company on Twitter: US_HEMP
To learn more about Puration: purationinc.com
Follow Puration on Twitter: Puration710
Visit Puration on Facebook: Facebook.com/puration/

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

Puration Contact:
Brian Shibley, CEO
[email protected]
+1-214-937-9097

SOURCE Puration, Inc.